PSX
42
3
GE
70
3
EFX
43
2
AMAT
57
-2
AVGO
68
-2
AME
50
-3
FCX
49
-4
EQT
65
11
DE
56
-2
DG
40
-2
NAVI
32
8
PGR
48
3
OKE
48
6
GT
21
-2
CTSH
42
-7
HON
62
10
HSIC
51
6
PBI
42
-4
ED
45
2
ALLE
39
7
PSX
42
3
GE
70
3
EFX
43
2
AMAT
57
-2
AVGO
68
-2
AME
50
-3
FCX
49
-4
EQT
65
11
DE
56
-2
DG
40
-2
NAVI
32
8
PGR
48
3
OKE
48
6
GT
21
-2
CTSH
42
-7
HON
62
10
HSIC
51
6
PBI
42
-4
ED
45
2
ALLE
39
7
Financhill
Back

Frontier Communications Parent Vs. Blueprint Medicines Industry Stock Comparison

Buy
57

FYBR
Frontier Communications Parent

Last Price:
$36.19
Seasonality Move:
14.15%
Buy
52

BPMC
Blueprint Medicines

Last Price:
$128.14
Seasonality Move:
10.35%
Buy
57
Frontier Communications Parent (FYBR) is a Buy

Is Frontier Communications Parent a Buy, Sell or Hold?

  • The current Frontier Communications Parent [FYBR] share price is $36.18. The Score for FYBR is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • FYBR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
52
Blueprint Medicines (BPMC) is a Buy

Is Blueprint Medicines a Buy, Sell or Hold?

  • The current Blueprint Medicines [BPMC] share price is $128.20. The Score for BPMC is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • BPMC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

FYBR Stock Price Chart

What is Frontier Communications Parent's stock price today?

  • The Frontier Communications Parent share price today is $36.18
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FYBR is experiencing selling pressure, which indicates risk of future bearish movement.

BPMC Stock Price Chart

What is Blueprint Medicines's stock price today?

  • The Blueprint Medicines share price today is $128.20
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing slight buying pressure.

FYBR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 42.63 Sell
Chaikin Money Flow: -2288417 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.18 - 36.62) Sell
Bollinger Bands (100): (35.75 - 36.39) Buy

BPMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 7.7 Buy
Relative Strength Index (14 RSI): 75.62 Buy
Chaikin Money Flow: 1502050 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (102.43 - 129.61) Buy
Bollinger Bands (100): (85.02 - 113.84) Buy

FYBR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 36.33 Sell
50-day SMA: 36.32 Sell
200-day SMA: 35.53 Buy
8-day EMA: 36.21 Sell
20-day EMA: 36.29 Sell
50-day EMA: 36.25 Sell
200-day EMA: 34.34 Buy

BPMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 128.11 Buy
20-day SMA: 119.69 Buy
50-day SMA: 103.32 Buy
200-day SMA: 95.92 Buy
8-day EMA: 127.3 Buy
20-day EMA: 120.82 Buy
50-day EMA: 109.36 Buy
200-day EMA: 98.18 Buy

Frontier Communications Parent Earnings Growth & FYBR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.01 per share, an increase this year of $0.21 per share, and a decrease next year of $0.01 per share.

Blueprint Medicines Earnings Growth & BPMC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.67 per share, an increase next quarter of $0.33 per share, an increase this year of $0.60 per share, and an increase next year of $1.50 per share.

Frontier Communications Parent Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):